A first step has been taken to identify the most critical healthcare services which should be examined as part of a massive national comparative effectiveness study underway. It's designed to eventually rein in the cost of healthcare in the U.S. and insure best use of existing health resources. (Medical Device Daily)

While many larger med-tech firms might be tightening belts to cope with the challenging economic climate, a smaller spinal device company continues to produce new products and report on expansions at a steady clip. (Medical Device Daily)

The days of cutting out cancerous tissue to examine under a microscope for a firm diagnosis may be numbered. By next year, Exosome Diagnostics (New York) expects to have blood-based cancer diagnostics on the market. (Diagnostics & Imaging Week)